Activated immune cells secrete tiny capsules bearing DNA that can enter other immune and tumor cells to stimulate the body’s defense systems, according to a study led by investigators at Weill Cornell Medicine.
Researchers found that nerves of the sympathetic nervous system are often abundant in melanomas, and can inhibit tumor growth by reducing local tumor-supportive macrophages.
Weill Cornell Medicine investigators made an unexpected finding that could open new avenues for therapies against inflammatory bowel disease, food allergy and other autoimmune conditions.
Weill Cornell Medicine researchers have demonstrated, for the first time, that Hodgkin lymphoma cancer cells from patient samples are immune cells stuck in an “identity crisis.”
A new preclinical study from Weill Cornell Medicine found that a protein long thought to be a foot soldier in the body’s defense against bacterial infection, does not actually help clear invaders the way its close cousin does.
Caring for a family member with dementia can feel like losing a loved one who is still alive, but a new study suggests that revisiting memories together through a simple digital tool can help ease that grief.
Weill Cornell Medicine investigators have revealed the detailed workings of a cell membrane protein; the discovery could lead to new therapies for blood coagulation disorders, cancers and other conditions.
Personalized approaches have dramatically improved outcomes for many patients with non-Hodgkin B-cell lymphomas yet the same is not true for patients with more rare lymphoma types that originate in T cells.
